macrophage galactose/N-acetylgalactosaminespecific C-type lectin (MMGL) is a type II transmembrane glycoprotein belonging to the C-type lectin family. Our development of monoclonal antibodies led us to discover that a calcium-dependent conformational change is detected by an antibody (termed mAb LOM-11) and that the antibody's binding to the respective site locks the lectin in an active conformation. These findings correspond to the divalent cation-mediated regulatory mechanisms in a family of cell adhesion molecule integrins that have gained much attention. We now provide direct evidence that mAb LOM-11 increases the affinity of the lectin for calcium ions as a mechanism for the conformational lock using a soluble recombinant form of MMGL (rML) produced in bacteria. Furthermore, we discovered by using an enzyme-linked immunosorbent assay that specific monosaccharides induced a binding site for mAb LOM-11 on the immobilized rML under low calcium environments. We also demonstrated that cell surface MMGL on a transfectant cell line underwent a conformational change upon addition of calcium or ligands, as detected by the binding of mAb LOM-11. These properties are reminiscent of ligand-induced binding sites defined for integrins. The present results suggest a possibility that the mAb LOM-11 binding site on the lectin may be a site at which proteinprotein interaction helps to fine tune the specificity of the C-type lectins by means of coordinated recognition mechanisms.
Introduction
Macrophages play versatile roles in the immune system and in the pathogenic process through phagocytosis, antigen presentation, cytokine production, and other effector functions. In these macrophage activities, in which carbohydrate recognition proteins (lectins) are thought to be deeply involved, cellular recognition and trafficking are essential. C-Type lectins constitute a group of molecules that play important roles in recognition events in a variety of biological processes (Drickamer, 1988) . Molecules in this group require calcium for the carbohydrate binding activity and have carbohydrate recognition domains (CRD) that share common structural features with each other. By crystallographic studies using CRD of mannose-binding protein and its genetically engineered form, two roles for calcium have been suggested (Weis et al., 1992; Kolatkar and Weis, 1996) : (1) maintenance of lectin structure and (2) direct involvement in the sugar binding site. It is conceivable that calcium may be a key component that regulates or participates in the recognition activity of C-type lectins. However, little is known about whether calcium could affect an overall conformation of C-type lectins that determines lectin activity or whether calcium is required locally as an essential component within carbohydrate binding sites.
We have been studying recognition mechanisms and biological functions of galactose (Gal)/N-acetylgalactosamine (GalNAc)-specific C-type lectin expressed on macrophages (MΦs). This type of lectin expressed in mice (MMGL) is a 42 kDa type II transmembrane glycoprotein with a single extracellular C-type CRD on its carboxyl terminus (Sato et al., 1992) . Using a recombinant soluble form of MMGL (rML), we have demonstrated MMGL to bind to highly branched galactose-terminated N-linked sugar chains, as well as to glycopeptides containing clustered O-linked chains with terminal GalNAc-Ser/Thr or terminal Galβ1-3GalNAc residues . MMGL and its rat homolog were originally found on peritoneal exudate MΦs (Oda et al., 1988; Ii et al., 1990) ; however, our recent studies revealed that it is specifically expressed in connective tissue MΦs in a large variety of organs Mizuochi et al., 1997) . This molecule has been suggested to be involved in the receptor-mediated endocytosis pathway of galactose-terminated glycoproteins (Ozaki et al., 1992; Kawakami et al., 1994) and in tumor cell recognition by MΦs in vitro (Oda et al., 1989; Kawakami et al., 1994; Sakamaki et al., 1995) . We also demonstrated that MMGL is expressed in tumor-infiltrating MΦs in mouse lung metastatic lesions produced by mouse ovarian tumor OV2944-HM-1 cells in vivo . The rat homolog of MMGL was reported to be expressed in rat cardiac allografts with arteriosclerosis as a pathogenic condition during the course of chronic rejection using a differential mRNA display technique (Russell et al., 1994) . A human molecule homologous to MMGL, termed HML, has also been cloned recently (Suzuki et al., 1996) .
In our previous study on MMGL, we discovered through an approach using monoclonal antibodies (mAb) that an overall conformational change occurs in response to changes in calcium concentrations . We have shown by solid phase enzyme-linked immunosorbent assays (ELISA) that one of the mAbs against MMGL (mAb LOM-11) binds to rML in a calcium-dependent manner. More importantly, the binding of mAb LOM-11 to the corresponding calcium-dependent epitope stabilized the carbohydrate binding activity (especially under low calcium environments) as revealed by an ELISA-based method for quantitatively measuring lectin activity of rML using fluorescein isothiocyanate-labeled galactose-conjugated polylysine (FITC-Gal-PLL) as a carbohydrate ligand (Imai and Irimura, 1994) . These results suggest that the binding of mAb LOM-11 produced a conformational lock of CRD. The presence of such sites responsible for the conformational lock of CRD may suggest the presence of a regulatory mechanism for lectin activity operating at the site of protein-protein interaction. The calciumdependent epitope was shown to be separate from the carbohydrate binding sites, because mAb LOM-11 did not block binding of FITC-Gal-PLL and because antibody competition experiments revealed that the mAb LOM-11 binding site was different from the sites for several mAbs that block carbohydrate binding . These results suggest that the ability to cause extensive changes in lectin conformation rather than local structural changes within the sugar binding pocket are related to the conformation lock.
In the study discussed here, we extended our previous work by investigating whether the calcium-dependent conformational change takes place on cell surface MMGL molecules. Second, we examined the possibility that the binding of mAb LOM-11 increases affinity of the calcium ion to rML as a mechanism of the conformational lock. Third, we asked whether the binding of specific monosaccharides could induce binding sites for mAb LOM-11 on immobilized rML as well as on cell surface MMGL. The last point is reminiscent of ligand-induced binding sites reported for integrins (Frelinger et al., 1988 (Frelinger et al., , 1991 Du et al., 1993) .
Results

Demonstration of a calcium-dependent epitope on cell surface MMGL
Our previous study left unanswered the question of whether a calcium-dependent conformational change also takes place in MMGL present on the cell surface. In other words, the question is whether a calcium-dependent binding of mAb LOM-11 could be detected not only on rML (produced in Escherichia coli) that lack glycosylation but also on cell surface MMGL with glycosylation and its transmembrane domain harbored in lipid bilayers. To address this question, we used CTLL-2 cells transfected with MMGL cDNA in an expression vector. CTLL-2 cell surface expression of MMGL, its glycosylation, and its carbohydrate binding activity have been established (Ichii et al., 1997) . Binding of mAbs to the transfectants was studied by flow cytometry (Figure 1 ). In this assay, the binding of mAbs to cell surface MMGL was detected by biotinylated anti-rat κ/λ light chains plus FITC-avidin D, and the fluorescence signals derived from individual cells were collected and presented in form of a histogram. In the presence of calcium, the mean fluorescence intensity of MMGL-transfected CTLL-2 cells treated with mAb LOM-11 plus second and third reagents was significantly (∼10-fold difference) higher than the intensity of the cells with control treatments (mAb omitted) (Figure 1b ). This result indicated that mAb LOM-11 significantly bound to the MMGL-transfected CTLL-2 cells in the presence of calcium. However, the same mAb did not bind to the transfectant cells in the presence of EGTA, as revealed by histograms fitting each other, regardless of the mAb treatment (Figure 1d ). In contrast, another anti-MMGL mAb, LOM-14, which binds to rML regardless of the presence of calcium through an independent epitope, bound not only in the presence of calcium but also in the presence of EGTA (Figure 1a,c) . These results demonstrated that the calcium-dependent conformational change also takes place (and was detected by mAb LOM-11) on glycosylated MMGL displayed on the cell surface. 
Calcium binding to rML is stabilized by the conformation-dependent antibody
We have previously shown that the binding of mAb LOM-11 to the corresponding calcium-dependent epitope stabilized the carbohydrate binding activity of rML (conformational lock) using an ELISA-based method (Imai and Irimura, 1994; Kimura et al., 1995) . In exploring the mechanism for the conformational lock, we tested effects of mAbs on the association of calcium ion with rML. One of the mAbs and rML were mixed after calcium depletion, followed by dialysis against buffer containing 10 -6 M of 45 Ca 2+ to allow radioactive calcium to bind to rML within a well of the microdialysis equipment. The mixture was then dialyzed against calcium-depleted buffer until counts in the dialysis buffer reached background level ( Figure 2a ). The radioactivity remaining in the wells was judged to represent calcium associated with rML. Under these experimental conditions, the radioactivity was higher in samples containing rML than in dialysis buffer. This result indicates that the binding of radioactive calcium to calcium-depleted rML can be measured. The counts retained were significantly higher in the presence of mAb LOM-11 relative to conditions in the presence of normal rat IgG or mAb LOM-14 (Figure 2b ), or in the absence of antibodies ( Figure 2c ). The sample containing mAb LOM-11 without rML did not exhibit significant calcium retention compared with the corresponding dialysis buffer. This result indicates that mAb LOM-11 itself did not adsorb calcium ion (Figure 2c ). 
Specific monosaccharides induce calcium-dependent epitope on immobilized rML under low calcium environments
We have previously shown that mAb LOM-11 stabilizes carbohydrate binding activity of immobilized rML . We examined an inverse situation in this study. Thus, we asked whether a specific carbohydrate could induce mAb LOM-11 binding sites. Binding of anti-MMGL mAbs to immobilized rML was compared in the presence or the absence of monosaccharides in the presence of 10 -5 M free calcium (Figure 3 ). Under these conditions, the binding of mAb LOM-11 was greatly enhanced in the presence of galactose or N-acetylgalactosamine (Figure 3a) . A 3-fold higher concentration was required for N-acetylgalactosamine than that for galactose to produce the same effect on mAb LOM-11 binding sites. Noncompetitive monosaccharides, mannose and N-acetylglucosamine, had no effect. Fucose had a slight effect, being 100-fold weaker than that of galactose. Binding of other mAbs that recognize independent epitopes was not affected by monosaccharides. These include the blocking mAbs that inhibit FITC-Gal-PLL binding to rML: LOM-4.9 (Figure 3c ), LOM-8.7 (Figure 3d ), LOM-4.7 (not shown), LOM-8.2 (not shown), and weakly blocking mAb LOM-14 (Figure 3b ). The enhancement of mAb LOM-11 binding by galactose was also seen at 10 -6 M, less impressively but still significantly at 10 -4 M, but not at 10 -3 M of free calcium (not shown).
Effect of monosaccharides on calcium-dependent epitope on cell surface MMGL
The effect of monosaccharides on the mAb LOM-11 binding to cell surface MMGL was studied by flow cytometry using MMGL-transfected CTLL-2 cells. Although binding of mAbs LOM-14 ( Figure 4b ) and LOM-4.9 (Figure 4c 
Discussion
Endogenous lectins are believed to play important roles in the process of recognition by cells through interaction with carbohydrate ligands. Three major categories of lectins, C-type lectins, galectins, and I-type lectins, have been identified (Drickamer, 1988; Powell and Varki, 1995) based on their structural similarities. Of these C-type lectins that require calcium to function exist as molecules with extremely diverse molecular context and function, including cell-cell adhesion molecules, extracellular matrix protein components, cellular receptors responsible for molecular uptake or signal transduction, and soluble proteins responsible for self-defense mechanisms. One question about these molecules is whether binding specificity defined only by the oligosaccharide portion of ligands could account for the specificity required for such diverse biological recognition processes. The importance of polypeptide molecules that can efficiently present carbohydrate ligands to C-type lectins has already been demonstrated (Imai et al., 1991; Lasky et al., 1992) . In the study discussed here, we investigated a conformational epitope on a C-type lectin (MMGL) as a case in which protein (antibody)-protein (lectin) interaction is closely related to the carbohydrate recognition process.
During efforts at development of mAbs against MMGL, by using a recombinant soluble form of MMGL produced in bacteria in an ELISA assay, we discovered an antibody (termed mAb LOM-11) that recognizes a calciumdependent active conformation of MMGL. It had not yet been established whether such a conformational change detected by mAb also takes place with MMGL in the form of a cell surface glycoprotein. To address this question, we used CTLL-2 cells transfected with MMGL cDNA. One advantage of using CTLL-2 transfectants is that a low background is observed upon flow cytometric analysis, because CTLL-2 cells do not express Fcγ receptors, whereas MΦs express these receptors at high density. We demonstrated that calcium-dependent binding of mAb LOM-11 was observed for cell surface MMGL expressed in an MMGL-transfected T cell line. The binding of mAb LOM-11 was abolished in the presence of EGTA (Figure 1 ) as well as in a calcium-EDTA buffer, controlling calcium concentration at 10 -5 M (Figure 4 ). Other anti-MMGL mAbs did not exhibit calciumdependent binding to cell surface MMGL. The results demonstrated that the calcium-dependent conformational change also takes place on the transmembrane form of MMGL displayed on the cell surface that has gone through posttranslational modification processes required for cell surface expression.
An important feature of mAb LOM-11 is its ability to stabilize the sugar binding activity of MMGL, especially under low calcium environments, presumably due to conformational lock. As one of the possibilities for explaining the conformational lock of MMGL, we examined whether calcium binding to rML is stabilized upon treatment with mAb LOM-11. After calcium depletion, rML and antibody were combined and dialyzed against buffer containing 10 -6 M 45 Ca 2+ to allow radioactive calcium to bind to rML. The unbound calcium was removed by dialysis against a calcium-depleted buffer. The radioactive calcium retained after dialysis was significantly higher upon treatment with mAb LOM-11 (Figure 2 ). The effect was specifically observed for mAb LOM-11 and was not attributable to an adsorption of calcium to antibody molecules themselves. These results suggest that binding of mAb LOM-11 to rML increased the affinity of calcium to the lectin domain by reducing the release rate of lectin-bound calcium. Alternatively, simultaneous binding of mAb LOM-11 and calcium to the respective binding sites took place. In either case, it is conceivable that the increased association of calcium with the lectin domain contributed to the stabilization of the lectin structure and to the conformational lock.
Our study revealed another interesting feature of the mAb LOM-11 binding site. When specific monosaccharides were available to the lectin, the binding of mAb LOM-11 was observed, even in relatively low calcium environments. This result is reminiscent of ligand-induced binding sites (LIBS) reported for integrins (Frelinger et al., 1988 (Frelinger et al., , 1991 Du et al., 1993) . The ligand specificity required for the LIBS (galactose and GalNAc specificity) is clearly observed here. Furthermore, the difference in the relative affinity between galactose and GalNAc was well conserved. That is, galactose is not only 3-fold more effective than GalNAc in the induction of the mAb LOM-11 binding site (Figure 3 ) but also 3-fold more effective in competing against binding of polyvalent ligands (FITC-Gal-PLL) to the immobilized rML (Imai and Irimura, 1994) . Mannose and N-acetylglucosamine did not produce such inductive effects, whereas fucose had a weak effect (100-fold weaker than galactose). Fucose did not significantly inhibit FITC-Gal-PLL binding to rML (Imai and Irimura, 1994) , but a partial inhibition of the binding of radiolabeled rML to galactose-conjugated beads was reported in an earlier study (Sato et al., 1992) . These results may indicate that the induction of the mAb LOM-11 binding site by monosaccharides is much more sensitive than the competitive inhibition against polyvalent carbohydrate ligands.
Taken together, the results indicate that only specific sugars can induce a particular epitope related to the active conformation of MMGL. Furthermore our results also demonstrate that a monosaccharide-induced conformational change also takes place for MMGL displayed on the cell surface (Figure 4) .
Based on the results of the work reported here and our previous studies, we summarized a schematic view of a coordinated mechanism for ligand recognition by MMGL in Figure 5 . In low calcium environments, the coordinated mechanism became evident. The mAb LOM-11 stabilized lectin-bound calcium (Figure 2 ). This may be responsible for the conformational lock that has been demonstrated as an enhancement of the lectin activity in our previous report . Specific sugars, in turn, induced the mAb LOM-11 binding site, presumably through the sugar binding site (Figures 3 and 4) . The sugar binding site and the mAb LOM-11 binding site, which have been shown to be spatially separated , may contribute to the ligand recognition in a concerted way.
A physiological problem is that the induction of the mAb LOM-11 epitope and the conformational lock produced by this antibody are seen at relatively low levels of free calcium (10 -6 to 10 -4 M). Because this concentration is still higher than that in cytosol (around 10 -7 M) (Letari et al., 1991) , one possibility is that such mechanisms are working in intracellular compartments. Indeed, our immunohistochemical study on lung interstitial MΦs revealed the presence of MMGL within intracellular vesicles . Another possibility is that relatively low levels of extracellular calcium might be physiological under certain tissue microenvironments. For example, keratinocytes are reported to proliferate at low levels of extracellular calcium (10 -5 to 10 -4 M), whereas they differentiate at millimolar levels in vitro (Pillai and Bikle, 1991) . Correspondingly, a gradient of extracellular calcium was observed in epidermis in vivo by ion-capture cytochemistry (Menon et al., 1985) .
Ligand-induced binding sites for integrins have been interpreted to represent an intermediate state of so-called outside-in signal transduction through integrins (Frelinger et al., 1988 (Frelinger et al., , 1991 Du et al., 1993) . Extensive studies have revealed that ligand occupancy facilitates association between integrin cytoplasmic domains and actin cytoskeleton/cytoskeleton-associated proteins. The effect of ligand occupancy was shown to be distinguishable from the effect of integrin clustering produced by multivalent ligands (Miyamoto et al., 1995) . The importance of ligand occupancy is also demonstrated in integrin-mediated cell motility (Felsenfeld et al., 1996) . Our results imply that carbohydrate ligand-induced transmission of signals may also exist for MMGL. Consequences of ligand occupancy on cell surface MMGL on MΦs are interesting subjects for further study. Interestingly, crystallographic studies on the A domain of α M β 2 integrins have revealed that ternary complex formation with magnesium, an acidic amino acid residue possibly provided by ligands, and amino acid residues of the integrin are likely to be responsible for the ligand binding mechanisms (Lee et al., 1995) . This may suggest that there are shared mechanisms in the ligand recognition processes, both for integrins and for C-type lectins, despite the ligands' being entirely different. It has been also speculated that the action of conformation-dependent antibodies as well as the presence of ligand-induced antibody binding sites may be based on common principles, such as stabilization of metal binding by antibodies (Figure 2 ), for both integrins and for C-type lectins where a divalent cation is a key component of ligand binding sites.
In addition, the present results showing a coordinated binding of sugar and antibody (protein) may suggest a coordinated mechanism for recognition of the carbohydrate and polypeptide portions of ligands by C-type lectins. Accumulating evidence indicates a possible role here for protein-protein interactions mediated by C-type lectins. Examples of this include recognition of major histocompatibility class I antigen by Ly49A on mouse natural killer cells (Karlhofer et al., 1992) and recognition of an acidic polypeptide segment of granulocyte PSGL-1 by P-selectin (Sako et al., 1995; Pouyani and Seed, 1995) .
In conclusion, we provide evidence showing a coordinated binding of monosaccharides and an antibody to macrophage C-type lectin, MMGL. The antibody was also demonstrated to stabilize calcium ion association to MMGL. These results will contribute to an understanding of ligand recognition mechanisms for C-type lectins, and possibly for integrins as well.
Materials and methods
Reagents
Glutathione, 2-mercaptoethanol, and biotin-conjugated monoclonal anti-rat κ and λ light chains were purchased from Sigma (St. Louis, MO), ethylenediaminetetraacetic acid (EDTA), ethyleneglycol-bis(β-aminoethylether)-N,N′-tetraacetic acid (EGTA), N-2-hydroxyethylpiperazine-N′-2-ethane sulfonic acid (HEPES), morpholino propane sulfonic acid (MOPS), and Tween 20 were from Wako Pure Chemical (Tokyo, Japan); bovine serum albumin (BSA), fraction V, was from Seikagaku Corp. (Tokyo, Japan); recombinant protein G-Sepharose 4B was from Zymed Laboratories Inc. (South San Francisco, CA); FITC-avidin D (cell sorter grade) was from Vector Laboratories, Inc. (Burlingame, CA); 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) was from Nacalai Tesque (Kyoto, Japan); Chelex 100 was from Bio-Rad (Hercules, CA); and 45 CaCl 2 was from DuPont/NEN (Boston, MA). An rML was affinity purified from Escherichia coli BL21(DE3) transformed with pET-8c containing the cDNA insert corresponding to extracellular regions of MMGL (amino acid 64-304), as described previously (Sato et al., 1992) .
Cells and monoclonal antibodies
Rat-rat hybridoma cell lines producing rat mAbs against MMGL were cultured in Dulbecco's modified Eagle's medium (Nissui Pharmaceutical, Tokyo, Japan) containing 4.5 g/l glucose, 10% heat-inactivated fetal bovine serum (Bioproducts, Inc., Walkersville, MD), 100 units/ml benzylpenicillin potassium (Wako), and 100 µg/ml streptomycin sulfate (Sigma) in a humidified atmosphere of 5% CO 2 , 95% air at 37_C. To prepare purified mAbs, culture supernatant was obtained in GIT serum-free medium (Wako) supplemented with 2 mM l-glutamine, 0.1 mM nonessential amino acids (Gibco-BRL, Gaithersburg, MD), 5.5% (v/v) NCTC-109 medium (Gibco), and penicillin/streptomycin as for Dulbecco's modified Eagle's medium. Monoclonal antibodies were purified using protein-G Sepharose 4B as described previously . A stable transfectant of CTLL-2 mouse T cell line transfected with an expression vector pCEP-4 (Invitrogen Co., San Diego, CA) having a full-length cDNA insert for MMGL (termed CTL-ML) and a mock-transfected CTLL-2 with pCEP-4 alone (termed CTL-CEP) were established. Details for production of these transfectant cell lines have been published in a separate paper (Ichii et al., 1997) . These transfectants were cultured in RPMI 1640 (Gibco) with 10% fetal bovine serum, 0.1 mM nonessential amino acids, 10 mM HEPES (pH 7.3), 5 × 10 -5 M 2-mercaptoethanol, 60 µg/ml kanamycin (Meiji Seika Co., Tokyo, Japan), recombinant human IL-2 (50 U/ml; kindly provided by Takeda Chemical Industries, Osaka, Japan), and 250 µg/ml hygromycin B (Calbiochem-Novabiochem Corp., La Jolla, CA).
Flow cytometric analysis
Hybridoma culture supernatants were diluted at 1:2 either in Dulbecco's phosphate-buffered saline (DPBS, containing 0.91 mM CaCl 2 , 0.49 mM MgCl 2 ) containing 0.1% BSA and 0.1% NaN 3 (calcium conditions), or in 10 mM sodium phosphate (pH 7.0), 0.15 M NaCl, 0.1% BSA, 0.1% NaN 3 , and 10 mM EGTA (EGTA conditions). CTL-ML cells (5 × 10 5 cells) or CTL-CEP cells were incubated for 30 min at 0_C in 100 µl of diluted hybridoma culture supernatants under calcium conditions or under EGTA conditions. To detect cell-bound antibodies, cells were subsequently incubated (30 min each) with biotinylated anti-rat κ/λ (1:200) , and then with FITC-avidin D (1:100). These second and third reagents were diluted in DPBS containing 0.1% BSA and 0.1% NaN 3 in the case of the calcium conditions, or in 10 mM sodium phosphate (pH 7.0), 0.15 M NaCl, 0.1% BSA, 0.1% NaN 3 , and 5 mM EGTA, for the EGTA conditions. Between incubation steps, cells were washed twice in the respective buffer. Immunofluorescence from viable cells was analyzed on a flow cytometer (Cyto Ace 150, JASCO, Tokyo, Japan) using a propidium iodide exclusion procedure as described previously (Sakamaki et al., 1995) . In some experiments, hybridoma culture supernatants were dialyzed against 20 mM MOPS (pH 8.5), 0.15 M NaCl, 10 mM EDTA to deplete calcium, and then against 20 mM MOPS (pH 7.0), 0.15 M NaCl (buffer A). CTL-ML cells were treated with 20 mM MOPS (pH 7.0), 0.15 M NaCl, 0.1 % NaN 3 , 0.1% BSA (buffer B) containing 5 mM EDTA for 10 min at 0_C to deplete cell-associated calcium. After washing in buffer B, cells were resuspended at 10 7 cells/ml in buffer B containing 5 mM EDTA, 4.96 mM CaCl 2 (buffer C) plus or minus 0.1 M galactose or 0.1 M mannose. Cells (50 µl suspension) were incubated with dialyzed-mAb (50 µl) for 30 min at 0_C. After washing twice in buffer C containing 50 mM of each respective sugar being tested, cell-bound mAbs were detected using biotinylated anti-rat κ/λ and FITC-avidin D diluted in buffer C on a flow cytometer as described.
Calcium binding
Calcium was depleted from purified antibody and from rML by dialysis against 20 mM MOPS (pH 8.5), 0.15 M NaCl, 10 mM EDTA and against 0.1 M Tris (hydroxymethyl) aminomethane (pH 10) (according to the method used for NKR-P1 (Bezouska et al., 1994) ), respectively. The antibody solution and the rML solution were then dialyzed against buffer A that had been deprived of calcium using Chelex 100. A mixture of rML (10 µg, 360 pmol) and antibody (40 µg, 270 pmol) in 0.1 ml total volume was dialyzed against buffer A containing 45 CaCl 2 (10 -6 M, 1,100 c.p.m./pmol) for 18 h at 4_C using a membrane of 8,000-molecular-weight cut-off in the well of a Microdialyzer System 100 (Pierce, Rockford, IL). Unbound 45 Ca was removed by dialysis against calcium-depleted buffer A changed at 4 h intervals (200 ml each for three times and then 100 ml each) until the radioactivity in the dialysis buffer reached background. Radioactivity remaining in the wells was determined using a solid scintillator Ready Cap (Beckman, Fullerton, CA) in a scintillation counter LSC-700 (Aloka, Tokyo, Japan).
ELISA assay
The affinity-purified rML (250 ng/well) was immobilized on wells of an ELISA plate (655061, Greiner, Frickenhausen, Germany), and the wells were blocked with 3% BSA . The immobilized rML was treated with buffer A containing 5 mM EDTA for 10 min at 25_C to deplete calcium, and then washed with buffer A containing 0.1% Tween-20. Purified mAb (0.1 µg in 100 µl) diluted in buffer A containing 5 mM EDTA, 4.96 mM CaCl 2 (calculated as 10 -5 M free calcium), 0.1% Tween-20, 1% BSA, and glutathione (100 µM reduced, 10 µM oxidized) was allowed to bind to rML for 1 h at 25_C in the presence or the absence of monosaccharides. The bound mAb was colorimetrically detected using biotinylated mouse mAb anti-rat κ/λ, peroxidase-labeled streptavidin and ABTS (substrate) as described .
